Ticker > Company >

Coral Laboratories share price

Coral Laboratories Ltd.

BSE: 524506 SECTOR: Pharmaceuticals & Drugs  14.96 K   33   1

493.65
-0.85 (-0.17%)
BSE: 06 Nov 04:01 PM

Price Summary

Today's High

₹ 509

Today's Low

₹ 490

52 Week High

₹ 896

52 Week Low

₹ 442.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

176.36 Cr.

Enterprise Value

100.05 Cr.

No. of Shares

0.36 Cr.

P/E

9.84

P/B

0.87

Face Value

₹ 10

Div. Yield

0.3 %

Book Value (TTM)

₹  570.37

CASH

79.87 Cr.

DEBT

3.56 Cr.

Promoter Holding

71.51 %

EPS (TTM)

₹  50.15

Sales Growth

37.47%

ROE

12.76 %

ROCE

17.04%

Profit Growth

52.99 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year37.47%
3 Year15%
5 Year10.26%

Profit Growth

1 Year52.99%
3 Year38.74%
5 Year27.64%

ROE%

1 Year12.76%
3 Year8.8%
5 Year8.67%

ROCE %

1 Year17.04%
3 Year11.64%
5 Year11.23%

Debt/Equity

0.0177

Price to Cash Flow

-144.29

Interest Cover Ratio

333.6865

CFO/PAT (5 Yr. Avg.)

0.188326474881251

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 71.51 0.00
Jun 2025 71.51 0.00
Mar 2025 71.51 0.00
Dec 2024 71.51 0.00
Sep 2024 71.51 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 38.736867040697% for the Past 3 years.
  • The company has shown a good revenue growth of 15.0034648399026% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 333.6865.
  • Company’s PEG ratio is 0.185776839474284.
  • The company has an efficient Cash Conversion Cycle of 35.498 days.
  • Company has a healthy liquidity position with current ratio of 7.0738.
  • The company has a high promoter holding of 71.51%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.30790736658682.

 Limitations

  • Company has negative cash flow from operations of -1.2223.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 31.66 32.23 22.99 28.14 18.82
Total Expenditure 20.92 25.72 16.67 25.45 16.64
Operating Profit 10.74 6.51 6.31 2.69 2.18
Other Income 1.56 2.54 2.52 2.48 2.05
Interest 0.03 0.01 0.02 0.04 0.06
Depreciation 0.49 0.51 0.5 0.51 0.45
Exceptional Items 0 0 0 -0.77 0
Profit Before Tax 11.78 8.53 8.31 3.85 3.72
Tax 2.97 2.15 2.17 1.03 1.16
Profit After Tax 8.81 6.38 6.14 2.83 2.57
Adjusted EPS (Rs) 24.64 17.86 17.2 7.91 7.18

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 96.57 75.61 78.12 83.66 115.01
Total Expenditure 80.72 67.4 74.31 67.42 88.77
Operating Profit 15.85 8.21 3.81 16.24 26.24
Other Income 3.77 4.81 6.9 6.63 9.11
Interest 0.04 0.14 0.34 0 0.1
Depreciation 1.98 1.99 2.18 1.98 2.01
Exceptional Items 0.02 0.96 0.04 -0.16 -0.77
Profit Before Tax 17.61 11.86 8.23 20.73 32.47
Tax 4.06 2.81 1.78 4.94 8.31
Net Profit 13.55 9.05 6.45 15.79 24.16
Adjusted EPS (Rs.) 37.94 25.32 18.04 44.19 67.61

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 3.57 3.57 3.57 3.57 3.57
Total Reserves 133.07 152.48 151.23 173.92 197.63
Borrowings 0 0 0 0 0
Other N/C liabilities 3.33 8.33 7.69 3.28 3.3
Current liabilities 27.56 25.52 11.86 24.9 24.96
Total Liabilities 167.54 189.9 174.35 205.68 229.46
Assets
Net Block 20.43 22.79 24.3 23.34 21.81
Capital WIP 0.5 1.72 0 0 2.48
Intangible WIP 0 0 0 0 0
Investments 14.1 24.43 17.41 24.04 24.8
Loans & Advances 2.88 9.17 8.13 3.51 2.9
Other N/C Assets 1.01 0.99 0.96 0.94 0.92
Current Assets 128.62 130.8 123.54 153.85 176.55
Total Assets 167.54 189.9 174.35 205.68 229.46
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 17.59 10.9 8.19 20.9 33.24
Adjustment -0.15 -0.01 0.38 -1.97 -3.01
Changes in Assets & Liabilities -13.08 -0.44 6.06 -19.51 -24.12
Tax Paid -3.43 -4.37 -1.97 -4.88 -7.33
Operating Cash Flow 0.93 6.08 12.67 -5.46 -1.22
Investing Cash Flow -0.07 -6.05 -2.61 1.4 -0.15
Financing Cash Flow 0.35 0.15 -6.43 0.01 2.71
Net Cash Flow 1.21 0.18 3.62 -4.06 1.33

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 71.51 71.51 71.51 71.51 71.51
chetan navinchandra doshi... 51.54 51.54 51.54 51.54 51.54
coral india finance and h... - 19.97 19.97 19.97 19.97
coral india finance and h... 19.97 - - - -
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
investors 28.49 28.49 28.49 28.49 28.49
iepf - - - - 2.49
llp - - 0.01 0.02 0.03
meeta samir sheth 1.84 1.84 1.84 1.84 1.84
noetic finance private li... 1.03 1.03 1.05 1.05 1.05
pooja bhagwandas 1.56 1.56 1.56 1.67 1.69
investor education and pr... - 2.49 2.49 2.49 -
nvestor education and pro... 2.38 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Coral Laboratories - Quaterly Results 13 Aug, 5:40 PM Coral Laboratories - Quaterly Results 13 Aug, 5:40 PM Coral Laboratories informs about closure of trading window 27 Jun, 12:56 PM Coral Laboratories - Quaterly Results 13 Feb, 6:55 PM Coral Laboratories informs about issuance of duplicate share certificate 31 Dec, 5:20 PM Coral Laboratories informs about newspaper publication 4 Sep, 5:05 PM Coral Laboratories - Quaterly Results 14 Aug, 4:43 PM Coral Laboratories - Quaterly Results 14 Aug, 4:43 PM Coral Laboratories informs about appointment of company secretary 13 Jul, 3:57 PM Coral Laboratories informs about resignation of CS cum CO 4 Jul, 5:11 PM Coral Laboratories - Quaterly Results 23 May, 2:56 PM Coral Laboratories - Quaterly Results 23 May, 2:56 PM Coral Laboratories - Quaterly Results 23 May, 2:56 PM Coral Laboratories informs about outcome of board meeting 8 Mar, 12:47 PM Coral Laboratories informs about outcome of board meeting 8 Mar, 12:37 PM Coral Laboratories - Quaterly Results 14 Feb, 2:20 PM Coral Laboratories - Quaterly Results 14 Feb, 2:20 PM Coral Laboratories informs about certificate 15 Jan, 5:00 PM Coral Laboratories informs about details of loss of certificate 16 Oct, 5:01 PM Coral Laboratories - Quaterly Results 12 Aug, 12:44 PM Coral Laboratories informs about loss of share certificate 7 Aug, 2:27 PM Coral Laboratories informs about press release 19 Jul, 3:02 PM Coral Laboratories informs about details of loss of certificate 15 Jul, 3:43 PM Coral Laboratories informs about AGM 11 Jul, 4:49 PM Coral Laboratories informs about loss of share certificate 1 Jun, 12:57 PM Coral Laboratories - Quaterly Results 23 May, 3:32 PM Coral Laboratories - Quaterly Results 23 May, 3:32 PM Coral Laboratories - Quaterly Results 23 May, 3:32 PM Coral Laboratories - Quaterly Results 14 Feb, 3:30 PM Coral Laboratories - Quaterly Results 11 Feb, 3:17 PM Coral Laboratories informs about outcome of board meeting 27 Sep, 3:55 PM Coral Laboratories informs about proceeding of 39th AGM 24 Sep, 2:09 PM Coral Laboratories informs about certificate 9 Jul, 11:55 AM Coral Laboratories informs about outcome of board meeting 27 May, 4:33 PM Coral Laboratories informs about newspaper publication 5 Nov, 3:07 PM Coral Laboratories informs about certificate 8 Oct, 3:07 PM Coral Laboratories informs about clarification on price movements 16 Apr, 10:44 AM

Coral Laboratories Stock Price Analysis and Quick Research Report. Is Coral Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Coral Laboratories. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Coral Laboratories has a PE ratio of 9.84433330142625 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Coral Laboratories has ROA of 11.1023% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Coral Laboratories has a Current ratio of 7.0738.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Coral Laboratories has a ROE of 12.757%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Coral Laboratories has a Debt to Equity ratio of 0.0177 which means that the company has low proportion of debt in its capital.

  • Sales growth: Coral Laboratories has reported revenue growth of 37.4668% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Coral Laboratories for the current financial year is 22.8157311010884%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Coral Laboratories is Rs 1.5 and the yield is 0.3039%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Coral Laboratories is Rs 50.1456. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Coral Laboratories in Ticker for free. Also, one can get the intrinsic value of Coral Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Coral Laboratories FAQs

Q1. What is Coral Laboratories share price today?
Ans: The current share price of Coral Laboratories is Rs 493.65.

Q2. What is the market capitalisation of Coral Laboratories?
Ans: Coral Laboratories has a market capitalisation of Rs 176.361399 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Coral Laboratories?
Ans: The PE ratio of Coral Laboratories is 9.84433330142625 and the P/B ratio of Coral Laboratories is 0.865489000847168, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Coral Laboratories share?
Ans: The 52-week high share price of Coral Laboratories is Rs 896, and the 52-week low share price of Coral Laboratories is Rs 442.55.

Q5. Does Coral Laboratories pay dividends?
Ans: Currently, Coral Laboratories pays dividends. Dividend yield of Coral Laboratories is around 0.3039%.

Q6. What are the face value and book value of Coral Laboratories shares?
Ans: The face value of Coral Laboratories shares is Rs 10, while the book value per share of Coral Laboratories is around Rs 570.3712. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Coral Laboratories?
Ans: Coral Laboratories has a total debt of Rs 3.5587 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Coral Laboratories?
Ans: The ROE of Coral Laboratories is 12.757% and ROCE of Coral Laboratories is 17.0396%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Coral Laboratories a good buy for the long term?
Ans: The Coral Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Coral Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Coral Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Coral Laboratories’s financials?
Ans: You can review Coral Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Coral Laboratories
X